fullerene c60 has been researched along with 1-methyl-4-phenylpyridinium in 1 studies
| Studies (fullerene c60) | Trials (fullerene c60) | Recent Studies (post-2010) (fullerene c60) | Studies (1-methyl-4-phenylpyridinium) | Trials (1-methyl-4-phenylpyridinium) | Recent Studies (post-2010) (1-methyl-4-phenylpyridinium) |
|---|---|---|---|---|---|
| 3,806 | 5 | 2,170 | 1,854 | 1 | 593 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, X; Feng, Z; Hou, B; Jia, H; Li, W; Liu, J; Liu, Z; Luo, C | 1 |
1 other study(ies) available for fullerene c60 and 1-methyl-4-phenylpyridinium
| Article | Year |
|---|---|
Polyhydroxylated fullerene derivative C(60)(OH)(24) prevents mitochondrial dysfunction and oxidative damage in an MPP(+) -induced cellular model of Parkinson's disease.
Topics: 1-Methyl-4-phenylpyridinium; Cell Death; Cell Line, Tumor; Cell Survival; DNA Damage; Electron Transport Chain Complex Proteins; Free Radical Scavengers; Fullerenes; Herbicides; Humans; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Diseases; Models, Biological; Neurons; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Reactive Oxygen Species | 2008 |